Food and Drug Administration (FDA) approved a new medication called Journavx (suzetrigine) to treat moderate to severe acute pain in adults. This...

WASHINGTON (AP) — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose...

U.S. federal officials have approved a new pain pill aimed at preventing addiction and overdose risks linked to opioids like Vicodin and OxyContin....

FRIDAY, Jan. 31, 2025 -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or...

FRIDAY, Jan. 31, 2025 -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or...

An FDA-approved medication called glucarpidase could serve as an antidote to kidney toxicity in patients receiving the chemotherapy drug methotrexate...

Chronic pain affects millions of people worldwide, but many current treatments come with serious risks. Opioids, commonly prescribed for severe pain,...

Scientists have discovered a new exoplanet, HD 20794 d, that could potentially support life. This exciting find comes from a team of researchers,...

People on hemodialysis for kidney failure often struggle with chronic pain, which is challenging to manage with opioids and other standard...

The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.